Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Quest Diagnostics Inc narrows FY 2014 outlook in line with analysts' estimates


Thursday, 24 Jul 2014 07:04am EDT 

Quest Diagnostics Inc:Expects FY 2014 Revenues to increase 2.5-3.5 pct compared to FY 2013, versus previous guidance of up 2-4 pct.Expects FY 2014 adjusted diluted EPS to be between $4.00 and $4.10, versus previous guidance of between $3.95 and $4.15.Reported revenue of $7.146 bln in FY 2013.FY 2014 revenue of $7.346 bln and EPS of $4.02 - Thomson Reuters I/B/E/S. 

Company Quote

66.34
0.78 +1.19%
19 Dec 2014